GLOBAL HEALTH INITIATIVE
The Global Health Initiative is a collaborative effort to develop novel solutions to complex global health problems. Our efforts combine various fields (biology, engineering) to develop a robust, reliable and inexpensive microfluidic chip that is capable of monitoring HIV from a fingerprick sample of whole blood, and E.coli in the food supply, and affordable in resource-limited settings.
RAPID HIV DETECTION
More than 35 million HIV-infected people live in the developing world, where resources are scarce. We have been developing low-cost diagnostic devices for global health problems, such as counting CD4+ T lymphocytes in HIV infected patients at resource limited settings. The absolute number of CD4+ T lymphocytes in blood is vital for evaluating HIV-infected patients and has important prognostic and therapeutic implications. Currently, these values are obtained through using a flow cytometer, which is a very expensive method. Moreover, we aim to develop technologies to capture various cell types from blood using nanoparticles, and microscale technologies.
CD4+ T-Lymphocyte Capture Using a Disposable Microfluidic Chip for HIV
USING MICRO-ELECTROMECHANICAL SYSTEMS (MEMS) TO DEVELOP DIAGNOSTIC TOOLS
RAPID INEXPENSIVE BACTERIA DETECTION
Using the same technologies to capture HIV for rapid diagnosis and detection in resource-limited settings, we aim to expand the capabilities of our technology to enable rapid, inexpensive testing of the food supply for E.coli infection
Comparison of the conventional culture method and the microchip based E. coli detection